Nephros Inc
NASDAQ:NEPH
Nephros Inc
Research & Development
Nephros Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nephros Inc
NASDAQ:NEPH
|
Research & Development
-$1.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-4%
|
|
|
Whirlpool Corp
NYSE:WHR
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hamilton Beach Brands Holding Co
NYSE:HBB
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cricut Inc
NASDAQ:CRCT
|
Research & Development
-$65.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Vesync Co Ltd
HKEX:2148
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sharkninja Inc
NYSE:SN
|
Research & Development
-$332.5m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nephros Inc
Glance View
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.
See Also
What is Nephros Inc's Research & Development?
Research & Development
-1.2m
USD
Based on the financial report for Sep 30, 2025, Nephros Inc's Research & Development amounts to -1.2m USD.
What is Nephros Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-4%
Over the last year, the Research & Development growth was -39%. The average annual Research & Development growth rates for Nephros Inc have been 1% over the past three years , 16% over the past five years , and -4% over the past ten years .
